Cargando…
Targeted next-generation sequencing has incremental value in the diagnostic work-up of patients with suspect pancreatic masses; a multi-center prospective cross sectional study
BACKGROUND: The diagnostic process of patients with suspect pancreatic lesions is often lengthy and prone to repeated diagnostic procedures due to inconclusive results. Targeted Next-Generation Sequencing (NGS) performed on cytological material obtained with fine needle aspiration (FNA) or biliary d...
Autores principales: | Achterberg, Friso B., Mulder, Babs G. Sibinga, Janssen, Quisette P., Koerkamp, Bas Groot, Hol, Lieke, Quispel, Rutger, Bonsing, Bert A., Vahrmeijer, Alexander L., van Eijck, Casper H. J., Roos, Daphne, Perk, Lars E., van der Harst, Erwin, Coene, Peter-Paul L. O., Doukas, Michail, Smedts, Frank M. M., Kliffen, Mike, van Velthuysen, Marie-Louise F., Terpstra, Valeska, Sarasqueta, Arantza Farina, Morreau, Hans, Mieog, J. Sven D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876380/ https://www.ncbi.nlm.nih.gov/pubmed/36696439 http://dx.doi.org/10.1371/journal.pone.0280939 |
Ejemplares similares
-
Real-time surgical margin assessment using ICG-fluorescence during laparoscopic and robot-assisted resections of colorectal liver metastases
por: Achterberg, Friso B., et al.
Publicado: (2020) -
Impact of resection margin status on recurrence and survival in pancreatic cancer surgery
por: Tummers, W. S., et al.
Publicado: (2019) -
Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma
por: Tummers, Willemieke S., et al.
Publicado: (2017) -
Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent
por: Hoogstins, Charlotte E. S., et al.
Publicado: (2018) -
Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial)
por: Suker, Mustafa, et al.
Publicado: (2019)